Skip to main content
. 2018 Aug 2;13(8):e0201515. doi: 10.1371/journal.pone.0201515

Table 1. Baseline characteristics of the development group and validation group.

Development group(n = 747) Validation group
(n = 317)
Z/χ2 P Value
Gender (%) 0.912 0.346
Male 422(56.5) 169(53.3)
Female 325(43.5) 148(46.7)
Age, year 53(43~63) 52(43~64) 0.298 0.765
Diabetes (%)
No 677(90.6) 281(88.6) 0.978 0.323
Yes 70(9.4) 36(11.4)
Hypertension (%)
No 567(75.9) 225(71.0) 2.838 0.105
Yes 180(24.1) 92(29.0)
Previous surgery of calculi (%) 0.591 0.472
No 573(76.7) 250(78.9)
Yes 174(23.3) 67(21.1)
Functional solitary kidney (%)
No 691(92.5) 292(92.1) 0.048 0.802
Yes 56(7.5) 25(7.9)
Maximum diameter of calculi, mm 10(7~14) 10(6–14) 0.092 0.927
Minimum diameter of calculi, mm 6(5~8) 6(4~8) 1.002 0.316
Mean CT attenuation value of calculi, Hu 0.715 0.699
<500 441(59.0) 195(61.5)
500~1000 251(33.6) 102(32.2)
>1000 55(7.4) 20(6.3)
Laterality of calculi (%) 0.569 0.461
Left 377(50.5) 168(53.0)
Right 370(49.5) 149(47.0)
Location of calculi (%) 1.850 0.397
Upper 382(51.2) 162(51.1)
Middle 116(15.5) 40(12.6)
Lower 249(33.3) 115(36.3)
Ipsilateral renal calculi (%) 2.490 0.119
No 442(59.2) 171(53.9)
Yes 305(40.8) 146(46.1)
Mean CT attenuation value of hydronephrosis, Hu 2.127 0.345
<8 573(76.7) 231(72.9)
8~16 132(17.7) 68(21.4)
>16 42(5.6) 18(5.7)
Degree of hydronephrosis (%) 3.769 0.152
Mild 454(60.8) 173(54.6)
Moderate 164(22.0) 84(26.5)
Severe 129(17.2) 60(18.9)
Urine WBC count (%) 0.761 0.859
No 384(51.4) 155(48.9)
Weakly positive 184(24.6) 81(25.6)
Moderately positive 100(13.4) 43(13.6)
Strongly positive 79(10.6) 38(12.0)
Urine nitrite (%) 0.191 0.669
No 705(94.4) 297(93.7)
Yes 42(5.6) 20(6.3)

CT, computer tomography; WBC, white blood cells.